Suppr超能文献

三周与六周固定治疗稳定型 Weber B 型踝关节骨折:随机、多中心、非劣效性临床试验。

Three week versus six week immobilisation for stable Weber B type ankle fractures: randomised, multicentre, non-inferiority clinical trial.

机构信息

Department of Surgery, Division of Orthopaedic and Trauma Surgery, Oulu University Hospital, Kajaanintie 50, PO Box 21, FI 90029 OYS, Oulu, Finland

Medical Research Centre (MRC) Oulu, Oulu, Finland.

出版信息

BMJ. 2019 Jan 23;364:k5432. doi: 10.1136/bmj.k5432.

Abstract

OBJECTIVE

To determine whether treatment of isolated stable Weber B type ankle fractures with a cast or a simple orthotic device for three weeks produces non-inferior outcomes compared with conventional immobilisation in a cast for six weeks.

DESIGN

Randomised, pragmatic, non-inferiority, clinical trial with blinded outcome assessment.

SETTING

Two major trauma centres in Finland, 22 December 2012 to 6 June 2016.

PARTICIPANTS

247 skeletally mature patients aged 16 years or older with an isolated Weber B type fibula fracture and congruent ankle mortise in static ankle radiographs.

INTERVENTIONS

Participants were randomly allocated to conventional six week cast immobilisation (n=84) or three week treatment either in a cast (n=83) or in a simple orthosis (n=80).

MAIN OUTCOME MEASURES

The primary, non-inferiority, intention-to-treat outcome was the Olerud-Molander Ankle Score at 12 months (OMAS; range 0-100; higher scores indicate better outcomes and fewer symptoms). The predefined non-inferiority margin for the primary outcome was -8.8 points. Secondary outcomes were ankle function, pain, quality of life, ankle motion, and radiographic outcome. Follow-up assessments were performed at 6, 12, and 52 weeks.

RESULTS

212 of 247 randomised participants (86%) completed the study. At 52 weeks, the mean OMAS was 87.6 (SD 18.3) in the six week cast group, 91.7 (SD 12.9) in the three week cast group, and 89.8 (SD 18.4) in the three week orthosis group. The between group difference at 52 weeks for the three week cast versus six week cast was 3.6 points (95% confidence interval -1.9 to 9.1, P=0.20), and for the three week orthosis versus six week cast was 1.7 points (-4.0 to 7.3, P=0.56). In both comparisons, the confidence intervals did not include the predefined inferiority margin of -8.8 points. The only statistically significant between group differences observed in the secondary outcomes and harms in the two primary comparisons were slight improvement in ankle plantar flexion and incidence of deep vein thrombosis, both in the three week orthosis group versus six week cast group.

CONCLUSION

Immobilisation for three weeks with a cast or orthosis was non-inferior to conventional cast immobilisation for six weeks in the treatment of an isolated stable Weber B type fracture.

TRIAL REGISTRATION

ClinicalTrials.gov NCT01758835.

摘要

目的

比较用石膏或简单矫形器治疗 3 周与传统石膏固定 6 周治疗孤立稳定型 Weber B 型踝关节骨折的效果,评估 3 周治疗是否不劣于 6 周传统石膏固定。

设计

随机、实用、非劣效性、临床试验,结局评估采用盲法。

地点

芬兰两家大型创伤中心,2012 年 12 月 22 日至 2016 年 6 月 6 日。

参与者

247 例骨骼成熟患者,年龄 16 岁及以上,均为静态踝关节 X 线片显示单纯 Weber B 型腓骨骨折且踝穴对位良好。

干预措施

参与者被随机分配到传统的 6 周石膏固定组(84 例)或 3 周治疗组,分别接受石膏固定(83 例)或简单矫形器固定(80 例)。

主要结局指标

主要的非劣效性、意向治疗结局是 12 个月时的 Olerud-Molander 踝关节评分(OMAS;范围 0-100;分数越高表明结局越好,症状越少)。主要结局的非劣效性边界设定为 -8.8 分。次要结局指标包括踝关节功能、疼痛、生活质量、踝关节活动度和影像学结局。随访评估在 6、12 和 52 周进行。

结果

247 例随机参与者中有 212 例(86%)完成了研究。52 周时,6 周石膏固定组的 OMAS 平均为 87.6(SD 18.3)分,3 周石膏固定组为 91.7(SD 12.9)分,3 周矫形器固定组为 89.8(SD 18.4)分。3 周石膏固定组与 6 周石膏固定组的组间差异为 3.6 分(95%置信区间 -1.9 至 9.1,P=0.20),3 周矫形器固定组与 6 周石膏固定组的组间差异为 1.7 分(-4.0 至 7.3,P=0.56)。这两次比较的置信区间均未包含 -8.8 分的劣效性边界。在这两个主要比较中,仅观察到次要结局和不良反应方面有统计学意义的组间差异,即 3 周矫形器组的踝关节跖屈角度略有改善,以及深静脉血栓形成的发生率略高于 6 周石膏固定组。

结论

用石膏或矫形器固定 3 周与传统石膏固定 6 周治疗孤立稳定型 Weber B 型骨折的效果相似。

临床试验注册

ClinicalTrials.gov NCT01758835。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce46/6342249/4bb896aa93f1/kort043141.va.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验